Alopecia

Edit

Kankakee hosts first Walk for Alopecia to raise awareness and funds

Kankakee Daily Journal 18 Jun 2026

Lauren Benedict is organizing Kankakee’s first Walk for Alopecia on Saturday, September 26, from 9 a.m ... The walk aims to raise awareness and funds for alopecia areata, an autoimmune disease ...

Edit

Alopecia Areata Market Emerging as a High-Growth Healthcare Investment Space Through 2036 – DelveInsight | ...

GetNews 17 Jun 2026

The Alopecia Areata market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period ... Some of the key facts of the Alopecia Areata Market Report . ... Key Alopecia Areata Companies ... Alopecia Areata Overview.

Edit

HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata (Form 8-K) (HCW Biologics Inc)

Public Technologies 16 Jun 2026

HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata ... About Alopecia Areata..

Edit

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

PR Newswire 08 Jun 2026

CG2001 is a topical fixed-dose combination formulation containing minoxidil and finasteride, being evaluated for the treatment of male androgenetic alopecia.

Edit

Alopecia Areata Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

GetNews 05 Jun 2026

Inactive Products Alopecia Areata Key Companies Alopecia Areata Key Products Alopecia Areata- Unmet Needs Alopecia Areata- Market Drivers and Barriers Alopecia Areata- Future Perspectives and ...

Edit

There’s more to life than hair: the 26-year-old posting positivity on alopecia

The National 23 May 2026

Hair is a curious thing, when you think about it ... ....

Edit

Samson Clinical Announces Last Patient Last Visit in its Pivotal Phase III Study of Sublingual Minoxidil for Male Androgenetic Alopecia

PR Newswire 18 May 2026

... Pty Ltd (Samson) announced completion of the Last Patient Last Visit in its pivotal Phase III clinical trial evaluating low dose sublingual minoxidil in male Androgenetic Alopecia (AGA)(SAM-002).

Edit

Alopecia:

BBC News 16 May 2026

Laura Mathias is asking people to think before they speak, after hurtful comments on her appearance. .

Edit

'I have alopecia but someone asked if I was dressed as Pitbull'

BBC News 16 May 2026

Laura Mathias is asking people to think before they speak, after hurtful comments on her appearance ... .

Edit

I have alopecia – I always have at least one small patch of hair loss on the go

The Irish Times 15 May 2026

I had a vague memory of Scottish actor Gail Porter developing alopecia and crying on telly with Richard and Judy ... [ Alopecia ... [ Alopecia ... – and alopecia universalis (complete body hair loss).

Edit

niostem’s electrotrichogenic wearable device shows significant hair density gains in men with androgenetic alopecia (Brightlands Venture Partners BV)

Public Technologies 07 May 2026

[...]. This is an abstract of the document. To keep reading, click here and get access to the original version. Attachments Original document Permalink. Disclaimer ... (noodl.

Edit

AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata

PR Newswire 28 Apr 2026

Food and Drug Administration (FDA) for upadacitinib (RINVOQ®; 15 mg and 30 mg, once daily) for the treatment of adult and adolescent patients with severe alopecia areata (AA), based on results from the Phase 3 UP-AA clinical program.1-3.

Edit

Analyst and Investor Event with Alopecia Areata Experts Presentation (802e33) (Nektar Therapeutics)

Public Technologies 20 Apr 2026

Rezpegaldesleukin in Patients with Severe-to-Very-Severe Alopecia Areata ... Alopecia Areata (REZOLVE-AA) Inflammatory Skin Disease ... Opportunity for REZPEG in Alopecia Areata (AA) ... National Alopecia Areata Foundation; 2 ... Alopecia Areata.

Edit

52-Week Topline Results from 16-Week Blinded Treatment Extension of REZOLVE-AA Demonstrate Deepening of Responses in Severe-to-Very-Severe Alopecia Areata with Rezpegaldesleukin (Form 8-K) (Nektar Therapeutics)

Public Technologies 20 Apr 2026

Demonstrate Deepening of Responses in Severe-to-Very-Severe Alopecia Areata with ... Results support advancement of rezpegaldesleukin into late-stage development in alopecia areata ... About Alopecia Areata.

Edit

52-Week Topline Results from 16-Week Blinded Treatment Extension of REZOLVE-AA Demonstrate Deepening of Responses in Severe-to-Very-Severe Alopecia Areata with Rezpegaldesleukin

PR Newswire 20 Apr 2026

Results support advancement of rezpegaldesleukin into late-stage development in alopecia areata ... REZOLVE-AA is a global study being conducted in 92 patients with severe-to-very-severe alopecia areata ... About Alopecia Areata ... Alopecia Areata.

Podcasts:

Latest News for: alopecia

Kankakee hosts first Walk for Alopecia to raise awareness and funds

Alopecia Areata Market Emerging as a High-Growth Healthcare Investment Space Through 2036 – DelveInsight | ...

HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata (Form 8-K) (HCW Biologics Inc)

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

Alopecia Areata Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

There’s more to life than hair: the 26-year-old posting positivity on alopecia

Samson Clinical Announces Last Patient Last Visit in its Pivotal Phase III Study of Sublingual Minoxidil for Male Androgenetic Alopecia

Alopecia:

'I have alopecia but someone asked if I was dressed as Pitbull'

I have alopecia – I always have at least one small patch of hair loss on the go

niostem’s electrotrichogenic wearable device shows significant hair density gains in men with androgenetic alopecia (Brightlands Venture Partners BV)

AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata

Analyst and Investor Event with Alopecia Areata Experts Presentation (802e33) (Nektar Therapeutics)

52-Week Topline Results from 16-Week Blinded Treatment Extension of REZOLVE-AA Demonstrate Deepening of Responses in Severe-to-Very-Severe Alopecia Areata with Rezpegaldesleukin (Form 8-K) (Nektar Therapeutics)

52-Week Topline Results from 16-Week Blinded Treatment Extension of REZOLVE-AA Demonstrate Deepening of Responses in Severe-to-Very-Severe Alopecia Areata with Rezpegaldesleukin

Article Search

EXPLORE WN.com